The novel pyridoxal-5′-phosphate derivative PPNDS potently antagonizes activation of P2X1 receptors
- 17 January 2000
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 387 (3), R19-R21
- https://doi.org/10.1016/s0014-2999(99)00834-1
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Chapter 9 Novel ligands for P2 receptor subtypes in innervated tissuesPublished by Elsevier ,1999
- Synthesis and structure-activity relationships of pyridoxal-6-arylazo-5?-phosphate and phosphonate derivatives as P2 receptor antagonistsDrug Development Research, 1998
- A Pyridoxine Cyclic Phosphate and Its 6-Azoaryl Derivative Selectively Potentiate and Antagonize Activation of P2X1 ReceptorsJournal of Medicinal Chemistry, 1998
- Design and pharmacology of selective P2‐purinoceptor antagonistsJournal of Autonomic Pharmacology, 1996
- Effects of P2-purinoceptor antagonists on degradation of adenine nucleotides by ecto-nucleotidases in folliculated oocytes of Xenopus laevisBiochemical Pharmacology, 1996
- PPADS, a novel functionally selective antagonist of P2 purinoceptor-mediated responsesEuropean Journal of Pharmacology, 1992